Director/PDMR Shareholding

Deltex Medical Group PLC
19 May 2006


                            Deltex Medical Group plc

                            Directors' Shareholdings
                           Grant of EMI Share Options

19 May 2006: Deltex Medical Group plc ('the Company'), the AIM listed
haemodynamic monitoring company, announces that the Board has today approved the
issue of share options to Andy Hill, Chief Executive and Ewan Phillips, Finance
Director under the Company's 2003 Enterprise Management Incentive Scheme ('EMI
Scheme'). This scheme allows the directors concerned to sacrifice their
entitlement to cash bonuses in return for share options at the nominal value of
1p per share. The details are as follows:

Name            No. of options    Exercise Exercise period Exercise period
                                   Price £            from              to

Andy Hill              154,085        0.01    See note (a)     19 May 2016
Ewan Phillips          259,225        0.01    See note (a)     19 May 2016

Note (a). Date of release of preliminary results for the year ended 31 December
2006.

In addition to the options outlined above, Mr Hill has an interest in the
following:

Name                 No. of   Exercise   Exercise period   Exercise period
                    options    Price £              from                to

Executive Share     200,000       0.25  27 November 2005  26 November 2012
Option Scheme
                    200,000       0.15   28 October 2006   27 October 2013
                    400,000       0.24   12 October 2007   11 October 2014
                    400,000     0.2075     28 March 2009     27 March 2016

EMI Scheme*         333,333       0.01     24 March 2004   27 October 2013
                    156,739       0.01     15 March 2005   11 October 2014

In addition to the options outlined above, Mr Phillips has an interest in the
following:

Name                 No. of   Exercise   Exercise period   Exercise period
                    options    Price £              from                to

Executive Share     100,000       0.25   7 November 2004   6 November 2011
Option Scheme
                     60,000       0.25  27 November 2005  26 November 2012
                    120,000       0.15   28 October 2006   27 October 2013
                    400,000       0.24   12 October 2007   11 October 2014
                    400,000     0.2075     28 March 2009     27 March 2016

EMI Scheme*         583,333       0.01     24 March 2004   27 October 2013
                    156,739       0.01     15 March 2005   11 October 2014

Mr Hill also has a beneficial interest in 172,486 ordinary shares in the Company
representing 0.23 per cent of the Company's issued ordinary share capital of the
company.

Mr Phillips also has a beneficial interest in 744,656 ordinary shares in the
Company representing 0.97 per cent of the Company's issued ordinary share
capital of the company.

All shares and options relate to ordinary 1p shares

For further information, please contact:-

Deltex Medical Group plc                                   01243 774 837
Nigel Keen, Chairman                        [e-mail]
Andy Hill, Chief Executive                   [e-mail]
Ewan Phillips, Finance Director          [e-mail]

Financial Dynamics                                         0207 831 3113
David Yates                                           [e-mail]
John Gilbert                                         [e-mail]



                      This information is provided by RNS
            The company news service from the London Stock Exchange